Injectable Drug Delivery Market Size, Analysis | Industry Report, 2022 - 2028
Description
Injectable Drug Delivery Market Size, Analysis | Industry Report, 2022 - 2028
Injectables offer maximum bioavailability of drugs towards the intended site of action and avoid the first pass metabolism. The injectable route is mostly preferred for the drugs which can’t be taken orally or have some stability problems. Unconscious patients or patients having low compliance towards oral tablets or capsules can be preferred for the injectable drug delivery therapy.
Market Dynamics
Increasing prevalence of chronic diseases such as diabetes, cardiac diseases, and anaphylaxis has supported growth of global injectable drug delivery market. According to the Allergy, Asthma & Clinical Immunology, in 2015, around 15 million people suffered from food allergies in the U.K. Similarly, according to the European Academy of Allergy and Clinical Immunology (EAACI), in 2015, around 17 million people suffered from food allergies in the U.K., of which around 3.5 million were children. Increasing awareness regarding safety and concern of needlestick injuries is a major factor driving growth of the injectable drug delivery market. For instance, the WHO recommended the use of safety syringes with sharp injury protection (SIP), in order to prevent needlestick injuries. Similarly, in May 2021, Innovative Neurons LLC announced to commercialize its patented auto retractable multi-needle syringe known as FAST (fast, accessible, safe, and technology) to decrease needlestick injuries. Various market players are focusing on the development and advancement in this space. For instance, ACT-O-VIAL System offered by Pfizer Inc. is a dual-component vial system that allows reconstitution of sterile, injectable medications by pressing on the plastic cap. The facility launch by market players to cater requirements of patients is expected to drive the market growth. For instance, in July 2018, Pfizer, Inc. announced to build sterile injectable pharmaceutical production facilities in the Michigan, U.S.
However, product recalls by the manufacturers is the major factors restraining the market over the forecast period. For instance, in April 2018, Becton Dickson and Company announced a recall of PosiFlush Heaparin Lock Flush Syringe, and Prefilled normal saline syringe, owing to the contamination with Serratia marcescens bacterium.
Key features of the study:
This report provides in-depth analysis of the injectables drug delivery market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global injectable drug delivery market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Becton, Dickinson and Company, Pfizer Inc., Novo Nordisk A/S, Gerresheimer AG, Carl-Zeiss-Stiftung, Terumo Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, SHL Group, Owen Mumford Limited, Injex Pharma GmbH.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
The global injectables drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injectable drug delivery market
Detailed Segmentation:
Global Injectable Drug Delivery Market, By Device Type:
Prefilled Syringes
Auto Injectors
Pens
Conventional Syringes
Cartridges
Ampoules
Vials
Others
Global Injectable Drug Delivery Market, By Material Type:
Glass
Plastic
Global Injectable Drug Delivery Market, By Usability:
Disposable
Reusable
Global Injectable Drug Delivery Market, By Route of Administration:
Intravenous
Intramuscular
Subcutaneous
Global Injectable Drug Delivery Market, By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
Global Injectable Drug Delivery Market, By Region:
North America
By Device Type:
Prefilled Syringes
Auto Injectors
Pens
Conventional Syringes
Cartridges
Ampoules
Vials
Others
By Material Type:
Glass
Plastic
By Usability:
Disposable
Reusable
By Route of Administration:
Intravenous
Intramuscular
Subcutaneous
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country:
U.S.
Canada
Latin America
By Device Type:
Prefilled Syringes
Auto Injectors
Pens
Conventional Syringes
Cartridges
Ampoules
Vials
Others
By Material Type:
Glass
Plastic
By Usability:
Disposable
Reusable
By Route of Administration:
Intravenous
Intramuscular
Subcutaneous
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Device Type:
Prefilled Syringes
Auto Injectors
Pens
Conventional Syringes
Cartridges
Ampoules
Vials
Others
By Material Type:
Glass
Plastic
By Usability:
Disposable
Reusable
By Route of Administration:
Intravenous
Intramuscular
Subcutaneous
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Device Type:
Prefilled Syringes
Auto Injectors
Pens
Conventional Syringes
Cartridges
Ampoules
Vials
Others
By Material Type:
Glass
Plastic
By Usability:
Disposable
Reusable
By Route of Administration:
Intravenous
Intramuscular
Subcutaneous
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Device Type:
Prefilled Syringes
Auto Injectors
Pens
Conventional Syringes
Cartridges
Ampoules
Vials
Others
By Material Type:
Glass
Plastic
By Usability:
Disposable
Reusable
By Route of Administration:
Intravenous
Intramuscular
Subcutaneous
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Device Type:
Prefilled Syringes
Auto Injectors
Pens
Conventional Syringes
Cartridges
Ampoules
Vials
Others
By Material Type:
Glass
Plastic
By Usability:
Disposable
Reusable
By Route of Administration:
Intravenous
Intramuscular
Subcutaneous
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Becton, Dickinson and Company*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Pfizer Inc.
Novo Nordisk A/S
Gerresheimer AG
Carl-Zeiss-Stiftung
Terumo Corporation
Vetter Pharma-Fertigung GmbH & Co. KG
SHL Group
Owen Mumford Limited
Injex Pharma GmbH
“*” marked represents similar segmentation in other categories in the respective section.
Injectables offer maximum bioavailability of drugs towards the intended site of action and avoid the first pass metabolism. The injectable route is mostly preferred for the drugs which can’t be taken orally or have some stability problems. Unconscious patients or patients having low compliance towards oral tablets or capsules can be preferred for the injectable drug delivery therapy.
Market Dynamics
Increasing prevalence of chronic diseases such as diabetes, cardiac diseases, and anaphylaxis has supported growth of global injectable drug delivery market. According to the Allergy, Asthma & Clinical Immunology, in 2015, around 15 million people suffered from food allergies in the U.K. Similarly, according to the European Academy of Allergy and Clinical Immunology (EAACI), in 2015, around 17 million people suffered from food allergies in the U.K., of which around 3.5 million were children. Increasing awareness regarding safety and concern of needlestick injuries is a major factor driving growth of the injectable drug delivery market. For instance, the WHO recommended the use of safety syringes with sharp injury protection (SIP), in order to prevent needlestick injuries. Similarly, in May 2021, Innovative Neurons LLC announced to commercialize its patented auto retractable multi-needle syringe known as FAST (fast, accessible, safe, and technology) to decrease needlestick injuries. Various market players are focusing on the development and advancement in this space. For instance, ACT-O-VIAL System offered by Pfizer Inc. is a dual-component vial system that allows reconstitution of sterile, injectable medications by pressing on the plastic cap. The facility launch by market players to cater requirements of patients is expected to drive the market growth. For instance, in July 2018, Pfizer, Inc. announced to build sterile injectable pharmaceutical production facilities in the Michigan, U.S.
However, product recalls by the manufacturers is the major factors restraining the market over the forecast period. For instance, in April 2018, Becton Dickson and Company announced a recall of PosiFlush Heaparin Lock Flush Syringe, and Prefilled normal saline syringe, owing to the contamination with Serratia marcescens bacterium.
Key features of the study:
This report provides in-depth analysis of the injectables drug delivery market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global injectable drug delivery market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Becton, Dickinson and Company, Pfizer Inc., Novo Nordisk A/S, Gerresheimer AG, Carl-Zeiss-Stiftung, Terumo Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, SHL Group, Owen Mumford Limited, Injex Pharma GmbH.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
The global injectables drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injectable drug delivery market
Detailed Segmentation:
Global Injectable Drug Delivery Market, By Device Type:
Prefilled Syringes
Auto Injectors
Pens
Conventional Syringes
Cartridges
Ampoules
Vials
Others
Global Injectable Drug Delivery Market, By Material Type:
Glass
Plastic
Global Injectable Drug Delivery Market, By Usability:
Disposable
Reusable
Global Injectable Drug Delivery Market, By Route of Administration:
Intravenous
Intramuscular
Subcutaneous
Global Injectable Drug Delivery Market, By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
Global Injectable Drug Delivery Market, By Region:
North America
By Device Type:
Prefilled Syringes
Auto Injectors
Pens
Conventional Syringes
Cartridges
Ampoules
Vials
Others
By Material Type:
Glass
Plastic
By Usability:
Disposable
Reusable
By Route of Administration:
Intravenous
Intramuscular
Subcutaneous
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country:
U.S.
Canada
Latin America
By Device Type:
Prefilled Syringes
Auto Injectors
Pens
Conventional Syringes
Cartridges
Ampoules
Vials
Others
By Material Type:
Glass
Plastic
By Usability:
Disposable
Reusable
By Route of Administration:
Intravenous
Intramuscular
Subcutaneous
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Device Type:
Prefilled Syringes
Auto Injectors
Pens
Conventional Syringes
Cartridges
Ampoules
Vials
Others
By Material Type:
Glass
Plastic
By Usability:
Disposable
Reusable
By Route of Administration:
Intravenous
Intramuscular
Subcutaneous
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Device Type:
Prefilled Syringes
Auto Injectors
Pens
Conventional Syringes
Cartridges
Ampoules
Vials
Others
By Material Type:
Glass
Plastic
By Usability:
Disposable
Reusable
By Route of Administration:
Intravenous
Intramuscular
Subcutaneous
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Device Type:
Prefilled Syringes
Auto Injectors
Pens
Conventional Syringes
Cartridges
Ampoules
Vials
Others
By Material Type:
Glass
Plastic
By Usability:
Disposable
Reusable
By Route of Administration:
Intravenous
Intramuscular
Subcutaneous
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Device Type:
Prefilled Syringes
Auto Injectors
Pens
Conventional Syringes
Cartridges
Ampoules
Vials
Others
By Material Type:
Glass
Plastic
By Usability:
Disposable
Reusable
By Route of Administration:
Intravenous
Intramuscular
Subcutaneous
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Becton, Dickinson and Company*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Pfizer Inc.
Novo Nordisk A/S
Gerresheimer AG
Carl-Zeiss-Stiftung
Terumo Corporation
Vetter Pharma-Fertigung GmbH & Co. KG
SHL Group
Owen Mumford Limited
Injex Pharma GmbH
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
262 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Device Type
- Market Snippet, By Material Type
- Market Snippet, By Usability
- Market Snippet, By Route of Administration
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Regulatory Scenario
- PEST Analysis
- Partnership and Acquisition Scenario
- Recent Product Launches/Approvals
- Technological Evolution
- Market Trends
- 4. Global Injectable Drug Delivery Market, By Device Type, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Auto Injectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Pens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Conventional Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Cartridges
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Ampoules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 5. Global Injectable Drug Delivery Market, By Material Type, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Glass
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Plastic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 6. Global Injectable Drug Delivery Market, By Usability, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Reusable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 7. Global Injectable Drug Delivery Market, By Route of Administration, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 8. Global Injectable Drug Delivery Market, By End User, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 9. Global Injectable Drug Delivery Market, By Region, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
- North America
- Market Size and Forecast, By Device Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Material Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Usability, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Device Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Material Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Usability, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Device Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Material Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Usability, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Device Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Material Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Usability, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Device Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Material Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Usability, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Device Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Material Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Usability, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- 10. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Becton, Dickinson and Company
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer Inc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novo Nordisk A/S
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Gerresheimer AG
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Carl-Zeiss-Stiftung
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Terumo Corporation
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Vetter Pharma-Fertigung GmbH & Co. KG
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- SHL Group
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Owen Mumford Limited
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Injex Pharma GmbH
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- 11. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 38 market data tables and 32 figures on "Injectable Drug Delivery Market - Global forecast to 2028”.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
